Alpha1H: A Unique Bladder Cancer Therapeutic, Acting with Great Precision

Project description

Novel highly efficient bladder cancer treatment with low toxicity

Fields of science

• medical and health sciences › clinical medicine › cancer › bladder cancer

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020-3
See other projects for this call

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)

Coordinator

HAMLET PHARMA AB

Address

Klinikgatan 32
222 42 Lund
Sweden

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 2 197 144,60